Overview
Title
To prohibit the Director of the National Science Foundation from awarding grants and other forms of assistance to Chinese communist military companies and their affiliates, and for other purposes.
ELI5 AI
The bill wants to make sure that U.S. science money doesn't go to companies in China that help the military, and it uses special lists to figure out which ones to avoid.
Summary AI
H. R. 254 aims to stop the Director of the National Science Foundation from giving grants or financial help to companies linked to the Chinese military. The bill specifically targets any individual or entity that has a relationship, like a research partnership or joint venture, with companies identified on specific federal lists, including those related to U.S. export regulations. The goal is to ensure that U.S. scientific resources are not inadvertently supporting military-linked entities in China.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
Summary of the Bill
The bill, titled the "American Science First Act," seeks to prevent the Director of the National Science Foundation (NSF) from awarding grants or providing other forms of assistance to any organization or individual associated with Chinese communist military companies and their affiliates. This encompasses a range of relationships, including research partnerships and joint ventures. The legislation outlines specific criteria to determine these affiliations based on entities listed under the Export Administration Regulations and various National Defense Authorization Acts.
Significant Issues
One of the primary issues with the bill is its dependence on existing lists, such as those maintained under the Export Administration Regulations and the National Defense Authorization Acts. These lists must be comprehensive and regularly updated to ensure that the bill's objectives are met. If they are neglected, there is a risk of oversight concerning which entities should be restricted from receiving NSF funds.
Additionally, the bill uses broad language, notably the phrase "affiliated or otherwise has a relationship," which could lead to varied interpretations. This ambiguity makes it challenging for those affected to precisely understand the restrictions applicable to them.
Another concern is the lack of clarity regarding how compliance with the bill will be monitored. The absence of specified mechanisms for enforcement and accountability introduces challenges in ensuring that funding is not mistakenly allocated to restricted entities. The complex nature of the language used in the bill, with its many cross-references to other regulatory documents, may necessitate legal expertise for complete comprehension.
Impact on the Public
Broadly, the bill aims to safeguard U.S. research and development resources by limiting the influence of foreign military organizations within national scientific endeavors. However, its implementation could inadvertently impact U.S. researchers and institutions due to the broad and ambiguous language, potentially causing some entities to lose funding if they are incorrectly deemed affiliated with restricted organizations.
Impact on Specific Stakeholders
For U.S. research institutions and academics, this bill might pose challenges in securing NSF funding for projects that involve international collaboration, particularly with entities linked—or deemed linked—to Chinese military companies. This could hinder cooperative research that might benefit from Chinese expertise or resources.
Conversely, the bill could positively affect national security stakeholders by tightening the veil over sensitive scientific research, ensuring that strategic information and technology do not indirectly assist foreign military operations. However, achieving this goal requires precise implementation and clear communication of the bill’s objectives and restrictions.
Overall, while the bill may enhance national security by safeguarding scientific funding, its effectiveness hinges on the accuracy of the lists it references and the clarity of its enforcement mechanisms.
Issues
The restriction on National Science Foundation grants is tied to specific lists, namely those from Export Administration Regulations and National Defense Authorization Acts, which could result in oversight if those lists are not comprehensive or not updated in a timely manner. This is a significant political and legal issue, as it could affect international relations and the enforcement of the bill's objectives. (Section 2)
The term 'affiliated or otherwise has a relationship' is broad and could be interpreted in various ways, potentially leading to uncertainty about which entities are affected by the restrictions. This ambiguity could result in legal and financial challenges for entities trying to comply with the law. (Section 2)
The section does not clarify how compliance will be monitored or what mechanisms are in place to ensure that grants are not improperly awarded. This lack of clarity could create challenges in enforcement and accountability, making it a significant legal and ethical issue. (Section 2)
The language of the bill could be considered complex due to the numerous cross-references to other regulatory documents, which may require additional legal expertise to fully understand. This complexity could pose a barrier to those affected by the bill, contributing to legal and financial uncertainties. (Section 2)
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of the Act states that it can be referred to as the "American Science First Act."
2. Restriction on National Science Foundation grants and other forms of assistance to Chinese communist military companies and their affiliates Read Opens in new tab
Summary AI
The section prohibits the National Science Foundation from giving grants or assistance to individuals or organizations linked to Chinese military companies or their affiliates. This includes relationships like research partnerships and joint ventures with certain entities listed under specific U.S. regulations and acts.